- About Us
- Clinical Trials
Available Clinical Trials
- Resources
- Contact Us
A Randomized Phase 3 Trial of Continuous vs. Intermittent Maintenance Therapy with Zanubrutinib as Upfront Treatment in Older Patients with Mantle Cell Lymphoma (INTERCON)
Eligible for screening study DCP 001